Custodiol

In recent times, custodiol has become increasingly relevant in various contexts. Custodiol HTK | The Clear Choice. Custodiol ® HTK Solution is intended for perfusion and flushing of donor heart, liver, kidney, and pancreas prior to removal from the donor for preserving these organs during hypothermic storage and transport to the recipient. Histidine-tryptophan-ketoglutarate - Wikipedia. Currently, HTK Solution is sold under the SERVATOR H or Custodial trademarks.

HTK solution is intended for perfusion and flushing of donor liver, kidney, heart, lung and pancreas prior to removal from the donor and for preserving these organs during hypothermic storage and transport to the recipient. Custodiol for myocardial protection and preservation: a .... Custodiol is an intracellular crystalloid cardioplegic solution used by some centres for myocardial protection in complex cardiac surgery and for organ preservation in transplant surgery.

CUSTODIOL — Koehler Pharmaceutical Asia. Franz Köhler, in collaboration with Prof. Bretschneider, developed the initial formulation of CUSTODIOL. Registered and approved for use in many countries worldwide.

- Cost-effective when compared with blood cardioplegia. Additionally, (15) Holistic support and dedicated training for our trusted partners. Custodiol Solution for cardioplegia /organ preservation .... Quick Reference: Custodiol Cardioplegia - Perfusion.com.

Initially Custodiol will be delivered at a line pressure of approximately 125 mmHg with the long plegia needle until an electrical arrest of the heart is achieved. The line pressure will then be reduced to approximately 75 mmHg for the remainder of the dose. ABOUT - Custodiol HTK. Custodiol® was originally designed as a cardioplegia solution and it effectively arrests the recovered heart. This level of arrest is not only electrical but also mechanical leading to reduced energy consumption.